Duan Jidong, chairman of Beijing Times Strategic Enterprise Management Consulting Co., Ltd., currently serves as a number of listed companies (Kang 600572, Wuhan Jianmin 600976, Huali Pharmaceutical 00607, Kunyao 600422, Shenzhen Stock Exchange 0110HK, Jinzhou Aohong, Jiangxi Renhe 00652). Special research fellow of the Institute of Listed Companies of China Academy of Social Sciences, director of the strategy committee of the board of directors of several well-known domestic enterprises such as Jinzhou Aohong Pharmaceutical, Shenzhen Hawking Pharmaceutical and Asian Pharmaceutical.
He has served as President of Huali Pharmaceutical Group, President of Kunming Pharmaceutical Group, Chairman of China-US Kunming Baker Norton Pharmaceutical Co., Ltd., Executive Deputy General Manager of China-US Guizhou Magic Pharmaceutical Co., Ltd., Deputy General Manager of Shandong Qilu Pharmaceutical Group, National Marketing Director of Sino-Swiss Beijing Monti Pharmaceutical Co., Ltd. and Director of Zhejiang Intel Pharmaceutical Co., Ltd.